SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-129457
Filing Date
2024-05-02
Accepted
2024-05-02 16:55:28
Documents
11
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d783552ddef14a.htm DEF 14A 463750
2 GRAPHIC g783552dsp2.jpg GRAPHIC 1056
3 GRAPHIC g783552dsp6.jpg GRAPHIC 4231
4 GRAPHIC g783552g76z73.jpg GRAPHIC 1084
5 GRAPHIC g783552g88p02.jpg GRAPHIC 40109
6 GRAPHIC g783552snap1.jpg GRAPHIC 88658
7 GRAPHIC g783552snap2.jpg GRAPHIC 4211
8 GRAPHIC g783552snap3.jpg GRAPHIC 3448
9 GRAPHIC g783552snap4.jpg GRAPHIC 2678
10 GRAPHIC g783552snap5.jpg GRAPHIC 3224
11 GRAPHIC g783552snap7.jpg GRAPHIC 3704
  Complete submission text file 0001193125-24-129457.txt   676135
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 843562323 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39248 | Film No.: 24909402
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)